HARNESSING MEDICAL ISOTOPES FOR IMPROVED HEALTHCARE

In collaboration with Canadian Nuclear Isotope Council (CNIC)

Medical isotopes play a pivotal role in advancing medical innovation and improving healthcare outcomes. Isotopes have diverse applications in medical diagnostics, treatment, and sterilization. Canada plays a central role of providing a secure supply of isotopes, in global isotope production, and acts as a platform enabling opportunities for collaboration and innovation in this critical field. How have nuclear isotopes revolutionized medical diagnostics and treatment, enabling more accurate disease detection and personalized therapies? What are the challenges in ensuring a secure and reliable supply of isotopes for medical applications, and how can Canada leverage its expertise to meet global demand? In what ways can the Canadian Nuclear Isotope ecosystem collaborate with research institutions, healthcare providers, and industry stakeholders to drive innovation and develop new applications for isotopes in healthcare?

SPEAKERS

Pam Damoff, Member of Parliament, Oakville North—Burlington, Ontario

David Harris, Co-Founder, President and CEO, Kinectrics

Rebecca Wong, Vice Chair, Education, Department of Radiation Oncology, University of Toronto; and Staff Radiation Oncologist, Princess Margaret Hospital

Ogimaa (Chief) Greg Nadjiwon, Chief of the Chippewas of Nawash Unceded First Nation

Moderated by James Scongack, Chief Development Officer and Executive Vice-President Operational Services, Bruce Power